147 related articles for article (PubMed ID: 15295222)
1. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine.
Talbot TR; Poehling KA; Hartert TV; Arbogast PG; Halasa NB; Mitchel E; Schaffner W; Craig AS; Edwards KM; Griffin MR
Pediatr Infect Dis J; 2004 Aug; 23(8):726-31. PubMed ID: 15295222
[TBL] [Abstract][Full Text] [Related]
2. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine.
Talbot TR; Poehling KA; Hartert TV; Arbogast PG; Halasa NB; Mitchel E; Schaffner W; Craig AS; Edwards KM; Griffin MR
Clin Infect Dis; 2004 Sep; 39(5):641-8. PubMed ID: 15356776
[TBL] [Abstract][Full Text] [Related]
3. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.
Hsu K; Pelton S; Karumuri S; Heisey-Grove D; Klein J;
Pediatr Infect Dis J; 2005 Jan; 24(1):17-23. PubMed ID: 15665705
[TBL] [Abstract][Full Text] [Related]
4. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.
Halasa NB; Grijalva CG; Arbogast PG; Talbot TR; Craig AS; Griffin MR; Schaffner W
Pediatr Infect Dis J; 2013 Jun; 32(6):604-9. PubMed ID: 23348816
[TBL] [Abstract][Full Text] [Related]
5. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
[TBL] [Abstract][Full Text] [Related]
6. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity.
Hennessy TW; Singleton RJ; Bulkow LR; Bruden DL; Hurlburt DA; Parks D; Moore M; Parkinson AJ; Schuchat A; Butler JC
Vaccine; 2005 Dec; 23(48-49):5464-73. PubMed ID: 16188350
[TBL] [Abstract][Full Text] [Related]
7. Racial and Regional Differences in Rates of Invasive Pneumococcal Disease.
de St Maurice A; Grijalva CG; Fonnesbeck C; Schaffner W; Halasa NB
Pediatrics; 2015 Nov; 136(5):e1186-94. PubMed ID: 26459652
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
[TBL] [Abstract][Full Text] [Related]
9. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.
Flannery B; Schrag S; Bennett NM; Lynfield R; Harrison LH; Reingold A; Cieslak PR; Hadler J; Farley MM; Facklam RR; Zell ER; Whitney CG;
JAMA; 2004 May; 291(18):2197-203. PubMed ID: 15138241
[TBL] [Abstract][Full Text] [Related]
10. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine.
Spicer JO; Thomas S; Holst A; Baughman W; Farley MM
Pediatr Infect Dis J; 2014 Feb; 33(2):158-64. PubMed ID: 24418837
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance among isolates causing invasive pneumococcal disease before and after licensure of heptavalent conjugate pneumococcal vaccine.
Karnezis TT; Smith A; Whittier S; Haddad J; Saiman L
PLoS One; 2009 Jun; 4(6):e5965. PubMed ID: 19536335
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009.
Wortham JM; Zell ER; Pondo T; Harrison LH; Schaffner W; Lynfield R; Thomas A; Reingold A; Bennett NM; Petit S; Aragon D; Bareta J; Juni BA; Farley MM; Beall B; Moore MR
Clin Infect Dis; 2014 May; 58(9):1250-7. PubMed ID: 24585565
[TBL] [Abstract][Full Text] [Related]
14. Persistent Sex Disparities in Invasive Pneumococcal Diseases in the Conjugate Vaccine Era.
de St Maurice A; Schaffner W; Griffin MR; Halasa N; Grijalva CG
J Infect Dis; 2016 Sep; 214(5):792-7. PubMed ID: 27247342
[TBL] [Abstract][Full Text] [Related]
15. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.
Tomczyk S; Lynfield R; Schaffner W; Reingold A; Miller L; Petit S; Holtzman C; Zansky SM; Thomas A; Baumbach J; Harrison LH; Farley MM; Beall B; McGee L; Gierke R; Pondo T; Kim L
Clin Infect Dis; 2016 May; 62(9):1119-25. PubMed ID: 26908787
[TBL] [Abstract][Full Text] [Related]
17. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
[TBL] [Abstract][Full Text] [Related]
18. Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution.
Izurieta P; Bahety P; Adegbola R; Clarke C; Hoet B
Expert Rev Vaccines; 2018 Jun; 17(6):479-493. PubMed ID: 29241390
[TBL] [Abstract][Full Text] [Related]
19. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
[TBL] [Abstract][Full Text] [Related]
20. Impact of PCV7/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD.
Ben-Shimol S; Greenberg D; Givon-Lavi N; Schlesinger Y; Miron D; Aviner S; Dagan R;
Vaccine; 2016 Aug; 34(38):4543-4550. PubMed ID: 27475471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
